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Abstract: Antibiotics are prescribed by dentists for treatment as well as prevention of infection. 
Indications for the use of systemic antibiotics in dentistry are limited, since most dental and 
periodontal diseases are best managed by operative intervention and oral hygiene measures. 
However, the literature provides evidence of inadequate prescribing practices by dentists, 
due to a number of factors ranging from inadequate knowledge to social factors. Here we 
review studies that investigated the pattern of antibiotic use by dentists worldwide. The main 
defects in the knowledge of antibiotic prescribing are outlined. The main conclusion is that, 
unfortunately, the prescribing practices of dentists are inadequate and this is manifested by 
over-prescribing. Recommendations to improve antibiotic prescribing practices are presented 
in an attempt to curb the increasing incidence of antibiotic resistance and other side effects 
of antibiotic abuse.
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Introduction
Dentists prescribe medications for the management of a number of oral conditions, 
mainly orofacial infections.1 Since most human orofacial infections originate from 
odontogenic infections,2 the prescribing of antibiotics by dental practitioners has 
become an important aspect of dental practice. For this reason, antibiotics account 
for the vast majority of medicines prescribed by dentists.3 Dentists prescribe between 
7% and 11% of all common antibiotics (betalactams, macrolides, tetracyclines, clin-
damycin, metronidazole).4 In the UK, for instance, dentists accounted for 7% of all 
community prescriptions of antimicrobials.5 On the other hand, the National Center for 
Disease Control and Prevention estimate that approximately one-third of all outpatient 
antibiotic prescriptions are unnecessary.6
Antibiotic prescribing may be associated with unfavorable side effects ranging from 
gastrointestinal disturbances to fatal anaphylactic shock and development of resistance. 
The increasing resistance problems of recent years are probably related to over- or 
mis-use of broad-spectrum agents such as cephalosporins and fluoro-quinolones.7 We 
have now entered an era where some bacterial species are resistant to the full range of 
antibiotics presently available, with the methicillin-resistant Staphylococcus aureus 
being the most widely known example of extensive resistance.3
These serious complications associated with antibiotics use have encouraged   studies 
investigating antibiotic prescribing practices of dentists.8–23
The PubMed database was searched in February 2010, and search criteria included: 
antibiotic, dentist, and prescribing. Searches were limited to human studies published 
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in English. Over 400 references were retrieved; 33 of them 
investigated antibiotic prescribing by dentists. These refer-
ences were reviewed to evaluate the therapeutic and prophy-
lactic antibiotic prescribing practices of dentists with a focus 
on indications of antibiotics, type of antibiotic prescribed, 
and the duration of prescription.
Therapeutic antibiotic prescribing 
by dentists
Most oral diseases presented to the dentist are primarily 
inflammatory conditions that are associated with pain. These 
inflammatory conditions and their associated clinical features 
are shown in Table 1. A considerable percentage of dental 
pain originates from acute and chronic infections of pulpal 
origin, which necessitates operative intervention,24 rather 
than antibiotics. Non-indicated clinical cases for antibiotic 
use include acute periapical infection, dry socket, and pulpi-
tis.15 Chronic inflammatory periodontal conditions are also 
not indicated for antibiotics; systemic antimicrobials should 
only be used in acute periodontal conditions where drainage 
or debridement is impossible, where there is local spread of 
the infection or where systemic upset has occurred.10
Data reported from different countries indicate differ-
ences in dentists’ knowledge of clinical situations indicated 
for antibiotics. Almost half or more of the dentists investi-
gated in England,8 Kuwait,15 and Turkey19 would prescribe 
for dry socket. Another non-indicated condition is localized 
swelling, which was also among the conditions for which 
antibiotics were prescribed in Norway,7 South Australia,14 
Kuwait,15and England.25 On the other hand, the figures for 
England show that admissions for ‘drainage of an abscess 
related to tooth has doubled from just under 800 in 1998 to 
almost 1600 in 2006.3
More common dental infections present in the form 
of pulpitis and periapical periodontitis, which require 
only operative measures like fillings, root canal therapy, 
or extraction if the tooth is not restorable. Unfortunately, 
dentists still prescribe antibiotics for this condition.8,11,15,17,
19,23,26,27 A distressing finding was that a number of dentists 
prescribe antibiotics for viral infections like herpes simplex 
virus-1 infections.11
Clinical situations that require antibiotic therapy on 
empirical basis are limited, and they include oral infection 
accompanied by elevated body temperature and evidence 
of systemic spread like lymphadenopathy and trismus.6 
Facial cellulitis that may or may not be associated with 
dysphagia,15 is a serious disease that should be treated by 
antibiotics promptly because of the possibility of infection 
spread via lymph and blood circulation, with development 
of septicemia.
There are also a limited number of localized oral lesions 
that are indicated for antibiotic use and these include peri-
odontal abscess, acute necrotizing ulcerative gingivitis, and 
pericoronitis.15
Another aspect of antibiotic over-prescribing is prescrib-
ing based on non-clinical factors. Patient’s expectation of 
Table 1 Orofacial painful/inflammatory conditions that may be encountered in dental practice and their important features
Inflammatory condition Important features
Reversible pulpitis Pain is poorly localized, of very short duration and may outlast the stimulus. Tooth is not tender to 
percussion. Normal radiographic appearance.
irreversible pulpitis Spontaneous attacks of pain ranging from few seconds to several hours. Pain is elicited by hot or 
cold applications. In its final stages, it is elicited by hot applications and relieved by cold applications.
Pain initially is not localized unless the periodontal ligament (PL) has become involved, which makes 
the tooth tender to percussion and makes the PL appear widened on radiographs.
Acute periapical periodontitis Pain is spontaneous, aggravated by biting, and related to a non-vital tooth.
Lateral periodontal abscess Affected tooth is associated with swollen gingiva, sensitive to percussion, mobile and vital. Pain is 
persistent.
Periodontitis Pain is localized, dull, with tenderness of associated teeth.
Pericoronitis Spontaneous pain, worse on biting. There are visible signs of inflammation of the operculum. May 
be associated with trismus, lymphadenopathy, and fever.
Cellulitis Swelling, tenderness, and erythema of the affected part of the face, with lymphadenopathy. The 
affected tooth is tender. May be associated with a dental abscess.
Dental hypersensitivity Pain is sharp, of short duration, and initiated by thermal stimuli and sweets.
Cracked tooth Pain is initiated by thermal stimuli, worse on biting, and difficult to diagnose.
Acute necrotizing gingivitis Bleeding gums with soreness and ulceration of interdental papillae. Associated with halitosis and 
sometimes fever.
Bacterial sialadenitis Affected salivary gland is swollen, tender, and painful especially at meal times. May be associated 
with trismus, fever, and lymphadenopathy.Therapeutics and Clinical Risk Management  2010:6 submit your manuscript | www.dovepress.com
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an antibiotic prescription, convenience, and demand neces-
sitated by the social background of the patients are considered 
unscientific reasons for antibiotic prescription. Whereas 
English and Scottish dentists would not prescribe for non-
clinical factors,25 dentists in the Eastern Mediterranean region 
have shown a tendency to prescribe on a patient’s demand 
or socially, especially when short of time.15,17
The most commonly used antibiotic in dental practice, 
penicillins in general, were found to be the most commonly 
prescribed antibiotics by dentists,16,17,20 the most popular one 
being amoxicillin,8,9,16,18,21,22 followed by penicillin V ,11,12,23 
metronidazole,8,9 and amoxicillin and clavulanate.28
Penicillin is still the gold standard in treating dental 
infections.6 Among the group of penicillins, penicillin V ,6 
amoxicillin,29 and amoxicillin and clavulanate30 have been 
advocated for the treatment of odontogenic infections. 
  Kuriyama et al found no difference in clinical outcome between 
penicillin V , amoxicillin, or amoxicillin and clavulanate.31
Frequency of prescribing is usually mentioned in the 
known resources for antibiotic prescribing,32 whereas dura-
tion of treatment recommended in therapeutic guidelines 
is most commonly based on expert opinion.33 A survey in 
Canada found that the average duration of antibiotic use 
prescribed by dentists is 6.92 days.13 Another survey in the 
USA found that endodontists prescribe antibiotic use for an 
average of 7.58 days.23 Recent studies on the attitudes of 
dentists in the Eastern Mediterranean region showed that 
dentists preferred to prescribe a lower dosage of an antibiotic 
over a longer period.15,18
In recent years, more attention has been given to short 
courses. Rubenstein explains that short-course antibiotic 
therapy requires that antibiotics have certain characteristics, 
such as: rapid onset of action, bactericidal activity, lack of 
propensity to induce resistant mutants, easy penetrability 
into tissues, activity against non-dividing bacteria, not being 
affected by adverse infection conditions (low pH, anaero-
biasis, presence of pus, etc.), administration at an optimal 
dose, and optimal dosing regimen.33 A two-dose, 3-gm 
regimen of amoxicillin has been shown to be effective in 
certain situations.34 On the other hand, oral antibiotic use for 
2 or 3 days has been advocated for the treatment of acute 
dentoalveolar infections, and in doses recommended by the 
British National Formulary (BNF).24 Indeed, in some studies, 
patients improved after 2 or 3 days of antibiotic therapy.31,35–37 
In general, reducing the frequency of antibiotic intake (with-
out compromising the dose) has yielded improved results: 
a twice-daily dosage of amoxicillin/clavulanate had several 
advantages over the three times-daily dosage, including 
increased convenience, improved compliance, and improved 
tolerability.38,39
Short courses are preferred to long courses particularly 
when treating children, since children’s compliance with 
conventional courses is poor.40 A false conception about 
the use of antibiotics is that antibiotics should be used for 
a certain number of days to ‘kill the resistant strains’ as the 
vast majority of strains acquire resistance via transposable 
elements that are preferentially transferred when antibiotics 
are used in sub-therapeutic doses or for long durations.41
In summary, antibiotics should be prescribed at the 
correct frequency, dose, and duration so that the minimal 
inhibitory concentration is exceeded, and so that side effects 
and the selection of resistant bacteria are prevented.8 Pro-
longed courses of antibiotics destroy the commensal flora.38 
In addition, longer durations of up to 21 days may result 
in the selection of resistant strains and a reduction in the 
ability of the oral flora to resist the colonization by harmful 
micro-organisms that are not normal residents,42 leading 
to superimposed infections by multi-resistant bacteria and 
yeasts.15
Prophylactic antibiotic prescribing
Prophylactic antibiotics, taken prior to a number of dental 
procedures, have been advocated to reduce the likelihood of 
postoperative local complications, like infection, dry socket, 
or serious systemic complications like infective endocardi-
tis. The evidence for antibiotics acting to prevent infection 
from surgical wounds in the mouth is poor to non-existent,14 
indicating that preoperative parenteral antibiotic prophylaxis 
for routine third molar surgery in medically fit patients is 
unwarranted.43,44 It was also found that a single dose of met-
ronidazole was ineffective in preventing the development of 
dry socket.45 For most dentoalveolar surgical procedures in 
fit, non-medically compromised patients, antibiotic prophy-
laxis is not required or recommended.46
In the case of bacterial endocarditis (IE), the absolute risk 
rate after dental treatment, even in at-risk patients, is con-
sidered very low.41 This is consistent with recent guidelines 
from the British Society for Antimicrobial Chemotherapy,47 
and the American Heart Association,48 which recommend 
that only patients in the high risk category require cover. 
The basis for this recommendation is:
•	 There is no consistent association between having an inter-
vention, dental or non-dental, and the development of IE.
•	 Regular tooth brushing almost certainly presents a greater 
risk of IE than a single dental procedure because of repeti-
tive exposure to bacteremia with oral flora. Therapeutics and Clinical Risk Management  2010:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
304
Dar-Odeh et al
•	 The clinical effectiveness of antibiotic prophylaxis is not 
proven.
•	 Antibiotic prophylaxis against IE for dental procedures 
may lead to a greater number of deaths through fatal 
anaphylaxis than would a strategy of no antibiotic pro-
phylaxis. Nor is antibiotic prophylaxis against IE cost 
effective.49
Most studies on prophylactic antibiotic use were car-
ried out in developed countries,8,9,11,13,14 and the results 
generally indicated that dentists have a good knowledge of 
prescribing.
The few studies done in developing countries15,17 reported 
that abuse of prophylactic antibiotics was to prevent postop-
erative infection following surgical dental manipulations15 
or to cover either a defect in aseptic clinical technique or 
improperly sterilized equipment; thus, a ‘just in case’ prin-
ciple is practiced.17
Recommendations
Recommended treatment modalities for common inflamma-
tory oral conditions are shown in Figure 1.
Drainage is the recommended treatment for periapical 
periodontitis and for localized dentoalveolar abscess, with 
incisional drainage rather than via the root canal preferred.31
Empirical antibiotic therapy and drainage are recom-
mended for more severe infections such as facial cellulitis, 
pericoronitis, lateral periodontal abscess, and necrotizing 
ulcerative gingivitis.
The type of antibiotic chosen and its dosing regimen are 
dependent upon the severity of infection and the predominant 
type of causative bacteria.
According to the BNF, amoxicillin is recommended for 
dental infections in doses ranging from 250 mg to 500 mg, 
every 8 hours.50 The use of 3 g amoxicillin repeated after 
8 hours is also mentioned, as a short course of oral   therapy.50 
Another antibiotic that is also recommended by the BNF 
is co-amoxiclav, which can be used in doses ranging from 
375 mg to 625 mg every 8 hours.51 In patients allergic to 
penicillin, clindamycin can be used in doses ranging from 
150 mg to 450 mg every 6 hours.52 Another option for 
penicillin-allergic patients (as recommended by the BNF) is 
metronidazole, which can be used in a dose of 200 mg every 
8 hours for 3–7 days.53
For severe odontogenic infections, higher doses of a 
broad-spectrum antibiotic may be required. Lewis et al 
have shown that only 5% of the main isolates from dental 
abscesses are resistant to amoxicillin/clavulinic acid.54 
A more recent study found that bacteria associated with endo-
dontic infections are completely susceptible to   amoxicillin/
clavulinic acid.55 Furthermore, some researchers observed 
that   amoxicillin/clavulinic acid and clindamycin are the only 
orally administered antimicrobials with adequate pharma-
cokinetic/pharmacodynamic properties to be effective against 
the most commonly isolated oral pathogens for the treat-
ment of orofacial infections.39 When amoxicillin/clavulinic 
acid is used, a dosing regimen of 1 g twice daily provides 
a successful clinical outcome, better patient convenience 
and compliance, and less gastrointestinal upset owing to 
the minimizing of the clavulinic acid dose.39 As mentioned 
previously, patients can be seen after 2 or 3 days to determine 
whether treatment should be stopped or continued.
Patients who are allergic to penicillin should benefit 
from clindamycin; it is active against some oral anaerobes 
and facultative bacteria, and has the advantage of good bone 
penetration. However, increasing the dose may increase the 
possibility of serious side effects such as pseudomembranous 
colitis,56–58 Sweet’s syndrome,59 and neutropenia.60
Infections in which anaerobic bacteria are implicated 
(such as pericoronitis, periodontal abscess and necrotizing 
ulcerative gingivitis) are better treated with metronidazole; 
the best dosage regimen in terms of pharmacodynamic/
pharmacokinetic aspect is 250 mg every 8 hours.39
Inflammatory
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Figure 1 Recommended treatment modalities for common inflammatory oral lesions.
Notes: *Operative intervention is needed, like filling, root canal treatment, local irrigation, incisional drainage, and oral hygiene measures. **Empirical antibiotic prescribing is 
needed as an initial treatment. Operative intervention(s) may be initiated on the same visit or later. Oral hygiene measures are mandatory.Therapeutics and Clinical Risk Management  2010:6 submit your manuscript | www.dovepress.com
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Other inflammatory/painful oral conditions such as 
cracked tooth, dentine hypersensitivity, and bacterial sialad-
entitis are outside the scope of this review and their manage-
ment is thoroughly explained in specialized references.
In addition to the proper dosing regimens and profes-
sionally responsible prescribing practices, the general public 
needs to be educated about the importance of restricting the 
use of antibiotics to only cases of severe infection. Patients 
have become accustomed to being given an antibiotic for a 
range of medical complaints. Unfortunately, patients present-
ing at dental surgeries also routinely expect an antibiotic for 
the treatment of ‘toothache’.3
Dental patients not only pressure their dentist to get 
an antibiotic prescription, they also self-medicate. Self-
medication with antibiotics was found to be alarmingly 
high in some developing countries.61–64 Also in Europe, 
self-prescription of antibiotics was reported, particularly in 
eastern and southern parts.65,66
In conclusion, prescribing practices of dentists can be 
improved by increasing awareness among dental practitioners 
of the recommended guidelines. Furthermore, the importance 
of initiating awareness programs among the general public 
should not be overlooked.
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